IgM contributes to glomerular injury in FSGS

Journal of the American Society of Nephrology

Volumn 24, Issue 3, 2013, Pages 393-406

  Strassheim, Derek ^a   Renner, Brandon ^a   Panzer, Sarah ^a   Fuquay, Richard ^a   Kulik, Liudmila ^a   Ljubanović, Danica ^b   Holers, V Michael ^a   Thurman, Joshua M ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b University of Zagreb School of Medicine   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

CD20 ANTIBODY; DOXORUBICIN; IMMUNOGLOBULIN M;

ALBUMINURIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN BINDING; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; FOCAL GLOMERULOSCLEROSIS; GLOMERULUS; HISTOPATHOLOGY; KIDNEY BIOPSY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEINURIA; SHOCK; T CELL DEPLETION;

EID: 84874595899     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2012020187     Document Type: Article

References (47)

1. Gephardt GN, Tubbs RR, Popowniak KL, McMahon JT: Focal and segmental glomerulosclerosis. Immunohistologic study of 20 renal biopsy specimens. Arch Pathol Lab Med 110: 902-905, 1986 (Pubitemid 17178410)
2. Habib R, Girardin E, Gagnadoux MF, Hinglais N, Levy M, Broyer M: Immunopathological findings in idiopathic nephrosis: Clinical significance of glomerular "immune deposits". Pediatr Nephrol 2: 402-408, 1988
3. Cohen AH, Border WA, Glassock RJ: Nehprotic syndrome with glomerular mesangial IgM deposits. Lab Invest 38: 610-619, 1978 (Pubitemid 8381140)
4. Lawler W, Williams G, Tarpey P, Mallick NP: IgM associated primary diffuse mesangial proliferative glomerulonephritis. J Clin Pathol 33: 1029-1038, 1980 (Pubitemid 11194194)
5. Ainsworth SK, Hirsch HZ, Brackett NC Jr., Brissie RM, Williams AV Jr., Hennigar GR: Diabetic glomerulonephropathy: Histopathologic, immunofluorescent, and ultrastructural studies of 16 cases. Hum Pathol 13: 470-478, 1982 (Pubitemid 12092903)
6. Mujais SK, Emmanouel DS, Kasinath BS, Spargo BH: Marked proteinuria in hypertensive nephrosclerosis. Am J Nephrol 5: 190-195, 1985 (Pubitemid 15120353)
7. Cavallo T, Johnson MP: Immunopathologic study of minimal change glomerular disease with mesangial IgM deposits. Nephron 27: 281-284, 1981 (Pubitemid 11072572)
8. Hsu HC, Chen WY, Lin GJ, Chen L, Kao SL, Huang CC, Lin CY: Clinical and immunopathologic study of mesangial IgMnephropathy: Report of 41 cases. Histopathology 8: 435-446, 1984
9. Zeis PM, Kavazarakis E, Nakopoulou L, Moustaki M, Messaritaki A, Zeis MP,Nicolaidou P:Glomerulopathy withmesangial IgMdeposits: Longterm follow up of 64 children. Pediatr Int 43: 287-292, 2001 (Pubitemid 32640948)
10. Alexopoulos E, Papagianni A, StangouM, Pantzaki A, PapadimitriouM: Adult-onset idiopathic nephrotic syndrome associated with pure diffuse mesangial hypercellularity. Nephrol Dial Transplant 15: 981-987, 2000 (Pubitemid 30410369)
11. Fernandez-Fresnedo G, Segarra A, González E, Alexandru S, Delgado R, RamosN, Egido J, PragaM; Trabajo de EnfermedadesGlomerulares de la Sociedad Española de Nefrología (GLOSEN): Rituximab treatment of adult patients with steroid-resistant focal segmental glomerulosclerosis. Clin J Am Soc Nephrol 4: 1317-1323, 2009
12. Gulati A, Sinha A, Jordan SC,Hari P,Dinda AK, Sharma S, Srivastava RN, Moudgil A, Bagga A: Efficacy and safety of treatment with rituximab for difficult steroid-resistant and -dependent nephrotic syndrome: Multicentric report. Clin J Am Soc Nephrol 5: 2207-2212, 2010
13. Pescovitz MD, Book BK, Sidner RA: Resolution of recurrent focal segmental glomerulosclerosis proteinuria after rituximab treatment. N Engl J Med 354: 1961-1963, 2006 (Pubitemid 43872718)
14. Ravani P, Magnasco A, Edefonti A, Murer L, Rossi R, Ghio L, Benetti E, Scozzola F, Pasini A, Dallera N, Sica F, BelingheriM, Scolari F, Ghiggeri GM: Short-term effects of rituximab in children with steroid-and calcineurin-dependent nephrotic syndrome: A randomized controlled trial. Clin J Am Soc Nephrol 6: 1308-1315, 2011
15. Sethna C, Benchimol C, Hotchkiss H, Frank R, Infante L, Vento S, Trachtman H: Treatment of recurrent focal segmental glomerulosclerosis in pediatric kidney transplant recipients: Effect of rituximab. J Transplant 2011: 389542, 2011
16. Suri M, Tran K, Sharma AP, Filler G, Grimmer J: Remission of steroidresistant nephrotic syndrome due to focal and segmental glomerulosclerosis using rituximab. Int Urol Nephrol 40: 807-810, 2008
17. Carroll MC, Holers VM: Innate autoimmunity. Adv Immunol 86: 137-157, 2005 (Pubitemid 40215692)
18. Baumgarth N: The double life of a B-1 cell: Self-reactivity selects for protective effector functions. Nat Rev Immunol 11: 34-46, 2011
19. Hayakawa K, Hardy RR,Herzenberg LA, Herzenberg LA: Progenitors for Ly-1 B cells are distinct from progenitors for other B cells. J Exp Med 161: 1554-1568, 1985 (Pubitemid 15046047)
20. Hamaguchi Y, Uchida J, Cain DW, Venturi GM, Poe JC, Haas KM, Tedder TF: The peritoneal cavity provides a protective niche for B1 and conventional B lymphocytes during anti-CD20 immunotherapy inmice. J Immunol 174: 4389-4399, 2005 (Pubitemid 40396022)
21. Haas MS, Alicot EM, Schuerpf F, Chiu I, Li J, Moore FD, Carroll MC: Blockade of self-reactive IgM significantly reduces injury in a murine model of acute myocardial infarction. Cardiovasc Res 87: 618-627, 2010
22. Fleming SD, Shea-Donohue T, Guthridge JM, Kulik L, Waldschmidt TJ, Gipson MG, Tsokos GC, Holers VM: Mice deficient in complement receptors 1 and 2 lack a tissue injury-inducing subset of the natural antibody repertoire. J Immunol 169: 2126-2133, 2002 (Pubitemid 34857679)
23. Zhang M, AustenWG Jr., Chiu I, Alicot EM, Hung R, Ma M, Verna N, Xu M, Hechtman HB, Moore FD Jr., Carroll MC: Identification of a specific self-reactive IgM antibody that initiates intestinal ischemia/reperfusion injury. Proc Natl Acad Sci U S A 101: 3886-3891, 2004 (Pubitemid 38381072)
24. Weiser MR, Williams JP, Moore FD Jr., Kobzik L, Ma M, Hechtman HB, Carroll MC: Reperfusion injury of ischemic skeletal muscle is mediated by natural antibody and complement. J Exp Med 183: 2343-2348, 1996 (Pubitemid 26158925)
25. Renner B, Strassheim D, Amura CR, Kulik L, Ljubanovic D, Glogowska MJ, Takahashi K, Carroll MC, Holers VM, Thurman JM: B cell subsets contribute to renal injury and renal protection after ischemia/reperfusion. J Immunol 185: 4393-4400, 2010
26. Peterson LK, Tsunoda I, Fujinami RS: Role of CD5+ B-1 cells in EAE pathogenesis. Autoimmunity 41: 353-362, 2008 (Pubitemid 351891196)
27. Wang Y, Wang YP, Tay YC, Harris DC: Progressive adriamycin nephropathy in mice: sequence of histologic and immunohistochemical events. Kidney Int 58: 1797-1804, 2000
28. Lenderink AM, Liegel K, Ljubanovic D, Coleman KE, Gilkeson GS, Holers VM, Thurman JM: The alternative pathway of complement is activated in the glomeruli and tubulointerstitium of mice with adriamycin nephropathy. Am J Physiol Renal Physiol 293: F555-F564, 2007 (Pubitemid 47358127)
29. Fornoni A, Sageshima J, Wei C, Merscher-Gomez S, Aguillon-Prada R, Jauregui AN, Li J, Mattiazzi A, Ciancio G, Chen L, Zilleruelo G, Abitbol C, Chandar J, Seeherunvong W, Ricordi C, Ikehata M, Rastaldi MP, Reiser J, Burke GW3rd: Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis. Sci Transl Med 3: 85ra46, 2011
30. Schwartz MM: Focal Segmental Glomerulosclerosis. In: Heptinstall's Pathology of the Kidney, edited by Jennette JC, Olson JL, Schwartz MM, Silva FG, 6th Ed., Philadelphia, Lippincott Williams & Wilkins, 2007, pp 155-204
31. Wang Y, Wang Y, Feng X, Bao S, Yi S, Kairaitis L, Tay YC, Rangan GK, Harris DC: Depletion of CD4(+) T cells aggravates glomerular and interstitial injury in murine adriamycin nephropathy. Kidney Int 59: 975-984, 2001 (Pubitemid 32206860)
32. Ji-Yun Y,Melvin T, Sibley R,Michael AF: No evidence for a specific role of IgM in mesangial proliferation of idiopathic nephrotic syndrome. Kidney Int 25: 100-106, 1984 (Pubitemid 14159390)
33. Morita Y, Ikeguchi H, Nakamura J, Hotta N, Yuzawa Y, Matsuo S: Complement activation products in the urine fromproteinuric patients. J Am Soc Nephrol 11: 700-707, 2000 (Pubitemid 30171879)
34. D'Agati VD, Fogo AB, Bruijn JA, Jennette JC: Pathologic classification of focal segmental glomerulosclerosis: A working proposal. Am J Kidney Dis 43: 368-382, 2004 (Pubitemid 38146337)
35. D'Agati V: The many masks of focal segmental glomerulosclerosis. Kidney Int 46: 1223-1241, 1994 (Pubitemid 24319965)
36. Turnberg D, Lewis M, Moss J, Xu Y, Botto M, Cook HT: Complement activation contributes to both glomerular and tubulointerstitial damage in adriamycin nephropathy in mice. J Immunol 177: 4094-4102, 2006 (Pubitemid 44359944)
37. Park P, HaasM, Cunningham PN, Bao L, Alexander JJ, Quigg RJ: Injury in renal ischemia-reperfusion is independent from immunoglobulins and T lymphocytes. Am J Physiol Renal Physiol 282: F352-F357, 2002 (Pubitemid 34654567)
38. Velosa J, Miller K, Michael AF: Immunopathology of the end-stage kidney. Immunoglobulin and complement component deposition in nonimmune disease. Am J Pathol 84: 149-162, 1976
39. Zwirner J, Felber E, Herzog V, Riethmüller G, Feucht HE: Classical pathway of complement activation in normal and diseased human glomeruli. Kidney Int 36: 1069-1077, 1989 (Pubitemid 20049214)
40. Faul C, DonnellyM,Merscher-Gomez S, Chang YH, Franz S, Delfgaauw J, Chang JM, Choi HY, Campbell KN, Kim K, Reiser J, Mundel P: The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A. Nat Med 14: 931-938, 2008
41. Atkinson JP, Frank MM: Effect of cortisone therapy on serum complement components. J Immunol 111: 1061-1066, 1973
42. Martin F, Chan AC: B cell immunobiology in disease: Evolving concepts from the clinic. Annu Rev Immunol 24: 467-496, 2006
43. Lemercier C, Julen N, Coulpier M, Dauchel H, Ozanne D, Fontaine M, Ripoche J: Differential modulation by glucocorticoids of alternative complement protein secretion in cells of the monocyte/macrophage lineage. Eur J Immunol 22: 909-915, 1992
44. Jafar TH, Stark PC, Schmid CH, Landa M, Maschio G, de Jong PE, de Zeeuw D, Shahinfar S, Toto R, Levey AS; AIPRD Study Group: Progression of chronic kidney disease: The role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: A patientlevel meta-analysis. Ann Intern Med 139: 244-252, 2003
45. Kriz W, LeHir M: Pathways to nephron loss starting from glomerular diseases-insights from animal models. Kidney Int 67: 404-419, 2005 (Pubitemid 40139832)
46. Kulik L, Fleming SD, Moratz C, Reuter JW, Novikov A, Chen K, Andrews KA, Markaryan A, Quigg RJ, Silverman GJ, Tsokos GC, Holers VM: Pathogenic natural antibodies recognizing annexin IV are required to develop intestinal ischemia-reperfusion injury. J Immunol 182: 5363-5373, 2009
47. Sargsyan SA, Serkova NJ, Renner B, Hasebroock KM, Larsen B, Stoldt C, McFann K, Pickering MC, Thurman JM: Detection of glomerular complement C3 fragments by magnetic resonance imaging in murine lupus nephritis. Kidney Int 81: 152-159, 2012